Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Nuvation Bio Inc. | CHIEF REGULATORY OFFICER | Stock Option (Right to Buy) | 500K | Feb 29, 2024 | Direct | ||
Flexion Therapeutics Inc | Chief Regulatory Officer | Common Stock | 0 | $8.50 | Nov 19, 2021 | By Spouse | |
Flexion Therapeutics Inc | Chief Regulatory Officer | Common Stock | 0 | $8.50 | Nov 19, 2021 | Direct | |
Flexion Therapeutics Inc | Chief Regulatory Officer | Stock Option (right to buy) | 0 | Nov 19, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NUVB | Nuvation Bio Inc. | Feb 29, 2024 | 1 | $0 | 4 | Mar 4, 2024 | CHIEF REGULATORY OFFICER |
NUVB | Nuvation Bio Inc. | Feb 28, 2023 | 1 | $0 | 4 | Mar 2, 2023 | Chief Regulatory Officer |
NUVB | Nuvation Bio Inc. | Aug 29, 2022 | 1 | $0 | 4 | Aug 31, 2022 | Chief Regulatory Officer |
NUVB | Nuvation Bio Inc. | May 23, 2022 | 2 | $0 | 4 | May 25, 2022 | Chief Regulatory Officer |
FLXN | Flexion Therapeutics Inc | Nov 19, 2021 | 11 | -$1.25M | 4 | Nov 19, 2021 | Chief Regulatory Officer |
FLXN | Flexion Therapeutics Inc | Jul 19, 2021 | 1 | -$25.4K | 4 | Jul 20, 2021 | Chief Regulatory Officer |
FLXN | Flexion Therapeutics Inc | Jun 21, 2021 | 1 | $4.19K | 4 | Jun 28, 2021 | Chief Regulatory Officer |
NUVB | Nuvation Bio Inc. | May 23, 2020 | 0 | $0 | 3 | May 25, 2022 | Chief Regulatory Officer |